Reduced Occupational Sitting in Type 2 Diabetes Using mHealth (Mobile Health)
ROSEBUD
1 other identifier
interventional
142
1 country
6
Brief Summary
Type 2 diabetes mellitus (T2DM) patients are suboptimal treated due to low uptake of physical activity. Recent research shows promising beneficial health effects from reducing sitting time by regular short bouts of light-intensity physical activity. These findings open up for a new focus in T2DM treatment but conclusive evidence is missing as studies have been short-term trials, mainly conducted in laboratory environments. Recent research suggest that reduced sitting and increased physical activity can be supported at a low cost by mHealth (mobile health) technology such as activity tracker armbands that warns of prolonged sitting and SMS text messages that reminds of activity breaks. The overarching purpose of the project is to evaluate the effects of an intervention aimed to reduce occupational sitting in T2DM using mHealth (mobile health). It is hypothesized that the intervention will lead to (1) Activity changes - reduced sitting time and/or increased number of steps (primary outcome measures) and (2) Health effects - lower fatigue, improved health-related quality of life, reduced cardiometabolic risk, less sick leave, less medication, less musculoskeletal problems (secondary outcome measures)
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for not_applicable diabetes-mellitus-type-2
Started Dec 2020
Longer than P75 for not_applicable diabetes-mellitus-type-2
6 active sites
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
January 2, 2020
CompletedFirst Posted
Study publicly available on registry
January 7, 2020
CompletedStudy Start
First participant enrolled
December 8, 2020
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 30, 2023
CompletedStudy Completion
Last participant's last visit for all outcomes
December 30, 2024
CompletedJanuary 18, 2024
January 1, 2024
3.1 years
January 2, 2020
January 15, 2024
Conditions
Outcome Measures
Primary Outcomes (1)
Sitting time
Assessed by activPAL3 thigh-worn accelerometer
12 months
Secondary Outcomes (7)
Steps
12 months
Fatigue
12 months
Health-related quality of life
12 months
Cardiometabolic composite score (CCMR)
12 months
Sick leave
12 months
- +2 more secondary outcomes
Other Outcomes (1)
General self-efficacy
12 months
Study Arms (2)
mHealth
EXPERIMENTAL1. Activity tracker armband (Garmin Vivofit); warns of prolonged sitting and counts daily steps. 2. SMS text messages; reminds of activity breaks. 3. Mobile video instruction for standing pause gymnastics.
Control
OTHERPatient-centered counselling and written material regarding occupational sedentary behaviour, with telephone follow-ups after 1 and 5 weeks.
Interventions
Patient-centered counselling and written material regarding occupational sedentary behaviour, with telephone follow-ups after 1 and 5 weeks.
1. Activity tracker armband (Garmin Vivofit); warns of prolonged sitting and counts daily steps. 2. SMS text messages; reminds of activity breaks. 3. Mobile video instruction for standing pause gymnastics.
Eligibility Criteria
You may qualify if:
- Type 2 Diabetes Melltitus
- years
- HbA1c 48-100 mmol/mol
- BMI ≥ 25 kg/m2
- Working at least 75% of full-time in a mainly seated job.
You may not qualify if:
- Pregnancy
- Regular vigorous intensity exercise
- Severe disease or for other reason unable to follow the study protocol
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Umeå Universitylead
- Norrbottens County Councilcollaborator
- Vastra Gotaland Regioncollaborator
- Region Östergötlandcollaborator
- Region Stockholmcollaborator
- Region Örebro Countycollaborator
- Region Västerbottencollaborator
- Region Jämtland Härjedalencollaborator
Study Sites (6)
Björkskatans Hälsocentral
Luleå, Norrbotten County, Sweden
Hallsbergs hälsocentral
Hallsberg, Sweden
Kärna Vårdcentral
Linköping, Sweden
Clinical Research Centre
Östersund, Sweden
Torsviks Vårdcentral
Stockholm, Sweden
Clinical Research Centre
Umeå, Sweden
Related Publications (1)
Syrjala MB, Bennet L, Dempsey PC, Fharm E, Hellgren M, Jansson S, Nilsson S, Nordendahl M, Rolandsson O, Radholm K, Ugarph-Morawski A, Wandell P, Wennberg P. Health effects of reduced occupational sedentary behaviour in type 2 diabetes using a mobile health intervention: a study protocol for a 12-month randomized controlled trial-the ROSEBUD study. Trials. 2022 Jul 27;23(1):607. doi: 10.1186/s13063-022-06528-x.
PMID: 35897022DERIVED
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Patrik Wennberg
Umeå University
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- SINGLE
- Who Masked
- OUTCOMES ASSESSOR
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Associate professor
Study Record Dates
First Submitted
January 2, 2020
First Posted
January 7, 2020
Study Start
December 8, 2020
Primary Completion
December 30, 2023
Study Completion
December 30, 2024
Last Updated
January 18, 2024
Record last verified: 2024-01
Data Sharing
- IPD Sharing
- Will not share